best performing mid cap stocks october 2011 to november 2012

Travere Therapeutics (TVTX) had the highest return between October 1, 2011 and November 30, 2012 by a mid-cap US stock, returning 167,400%.

ASSETDATE% RETURN
Travere Therapeutics (TVTX)
10/1/2011 - 11/30/2012
167,400%
Aurinia Pharmaceuticals (AUPH)
10/1/2011 - 11/30/2012
3,210.34%
Par Pacific (PARR)
10/1/2011 - 11/30/2012
1,800%
Patrick Industries (PATK)
10/1/2011 - 11/30/2012
839.61%
ACADIA Pharmaceuticals (ACAD)
10/1/2011 - 11/30/2012
385.98%
Builders FirstSource (BLDR)
10/1/2011 - 11/30/2012
312.7%
M/I Homes (MHO)
10/1/2011 - 11/30/2012
269.3%
HCI (HCI)
10/1/2011 - 11/30/2012
247.92%
Louisiana-Pacific (LPX)
10/1/2011 - 11/30/2012
243.59%
Eagle Materials (EXP)
10/1/2011 - 11/30/2012
228.33%
Lakefront Biotherapeutics (LKFT)
10/1/2011 - 11/30/2012
175.93%
NeoGenomics (NEO)
10/1/2011 - 11/30/2012
170.46%
Celldex Therapeutics (CLDX)
10/1/2011 - 11/30/2012
161.67%
DXP Enterprises (DXPE)
10/1/2011 - 11/30/2012
159.21%
Trex (TREX)
10/1/2011 - 11/30/2012
156.22%
Lithia Motors (LAD)
10/1/2011 - 11/30/2012
155.81%
KB Home (KBH)
10/1/2011 - 11/30/2012
154.58%
Fortune Brands Innovations (FBIN)
10/1/2011 - 11/30/2012
149.92%
Madrigal Pharmaceuticals (MDGL)
10/1/2011 - 11/30/2012
149.85%
Delek US Energy (DK)
10/1/2011 - 11/30/2012
146.59%
Acadia Healthcare (ACHC)
10/1/2011 - 11/30/2012
144.15%
Prestige Brand (PBH)
10/1/2011 - 11/30/2012
141.34%
Banner (BANR)
10/1/2011 - 11/30/2012
138.56%
Terex (TEX)
10/1/2011 - 11/30/2012
138.32%
American Airlines (AAL)
10/1/2011 - 11/30/2012
136.95%
Mid-cap stocks are treated as having a market cap between $2B and $10B.